Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ultragenyx Pharmaceutical

35.69
+0.71002.03%
Post-market: 35.63-0.0600-0.17%16:31 EDT
Volume:690.76K
Turnover:24.54M
Market Cap:3.35B
PE:-5.68
High:35.74
Open:35.00
Low:34.74
Close:34.98
Loading ...

BofA Adjusts Price Target on Ultragenyx Pharmaceutical to $80 From $83, Keeps Buy Rating

MT Newswires Live
·
17 Apr

Ultragenyx Pharmaceutical (RARE): Among Billionaire Stanley Druckenmiller’s Top Stock Picks with Huge Upside Potential

Insider Monkey
·
14 Apr

US FDA Animal Testing De-Emphasis May Boost Biotech Innovation, RBC Says

MT Newswires Live
·
11 Apr

Ultragenyx (RARE) Soars 9.2%: Is Further Upside Left in the Stock?

Zacks
·
10 Apr

RBC Capital Sticks to Its Buy Rating for Ultragenyx Pharmaceutical (RARE)

TIPRANKS
·
05 Apr

Ultragenyx Pharmaceutical (RARE) Gets a Buy from Truist Financial

TIPRANKS
·
03 Apr

Why Ultragenyx Pharmaceutical (RARE) Is Among the Best Mid Cap Biotech Stocks to Buy

Insider Monkey
·
30 Mar

BUZZ-Ultragenyx Pharma up after JPMorgan PT raise

Reuters
·
27 Mar

Ultragenyx Pharma Is Maintained at Overweight by JP Morgan

Dow Jones
·
27 Mar

Ultragenyx Pharmaceutical Inc : JP Morgan Raises Target Price to $117 From $104

THOMSON REUTERS
·
27 Mar

Top Analyst Reports for Shell, Uber & TotalEnergies

Zacks
·
20 Mar

BRIEF-Ultragenyx reports inducement grant under Nasdaq listing rule 5635(C)(4)

Reuters
·
20 Mar

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
20 Mar

Watch Out: 23 Altcoins Have Massive Token Unlocks in the New Week – Here’s the Day-by-Day, Hour-by-Hour List

CoinMarketCap
·
17 Mar

SuperRare (RARE) Climbs 50%, But Correction Risks Increase

BE[IN]CRYPTO
·
11 Mar

Ultragenyx Pharmaceutical (RARE) Gets a Buy from J.P. Morgan

TIPRANKS
·
08 Mar

Ultragenyx Pharmaceutical: Strong Buy Rating Backed by Growth Potential and Robust Pipeline

TIPRANKS
·
07 Mar

NYSE CONTENT ADVISORY: PRE-MARKET UPDATE + RARE DISEASE DAY AWARENESS

PR Newswire
·
28 Feb

Ultragenyx Pharma Price Target Maintained With a $118.00/Share by Cantor Fitzgerald

Dow Jones
·
26 Feb

Ultragenyx to Participate at Investor Conferences in March

GlobeNewswire
·
25 Feb